Publication:
Pegylatedd interferon alfa-2b monotherapy and pegylated interferon alfa-2b plus lamivudine combination therapy for patients with hepatitis B virus E antigen-negative chronic hepatitis B

Simple item page
dc.contributor.authorKaymakoglu, Sabahattin
dc.contributor.authorOğuz, Dilek
dc.contributor.authorGür, Gürden
dc.contributor.authorGürel, Selim
dc.contributor.authorTankurt, Ethem
dc.contributor.authorErsöz, Galip
dc.contributor.authorÖzenirler, Seren
dc.contributor.authorKalaycı, Cem
dc.contributor.authorPoturoğlu, Şule
dc.contributor.authorÇakaloğlu, Yılmaz
dc.contributor.authorOkten, Atilla
dc.contributor.buuauthorGÜREL, SELİM
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Gastroenteroloji Anabilim Dalı.
dc.contributor.researcheridHLH-8209-2023
dc.date.accessioned2024-11-08T05:23:52Z
dc.date.available2024-11-08T05:23:52Z
dc.date.issued2007-08-01
dc.description.abstractForty-eight hepatitis B virus (HBV) E antigen-negative chronic hepatitis B patients received pegylated interferon alfa-2b either alone or with lamivudine for 48 weeks and were followed for an additional 24 weeks. At the end of follow-up, virological response rates (HBV DNA levels of < 400 copies/ml) were similar in the monotherapy (24%) and combination therapy (26%) groups.
dc.identifier.doi10.1128/AAC.00088-07
dc.identifier.endpage3022
dc.identifier.issn0066-4804
dc.identifier.issue8
dc.identifier.startpage3020
dc.identifier.urihttps://doi.org/10.1128/AAC.00088-07
dc.identifier.urihttps://journals.asm.org/doi/10.1128/aac.00088-07
dc.identifier.urihttps://hdl.handle.net/11452/47592
dc.identifier.volume51
dc.identifier.wos000248523700056
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherAmer Soc Microbiology
dc.relation.journalAntimicrobial Agents and Chemotherapy
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectMicrobiology
dc.subjectPharmacology & pharmacy
dc.titlePegylatedd interferon alfa-2b monotherapy and pegylated interferon alfa-2b plus lamivudine combination therapy for patients with hepatitis B virus E antigen-negative chronic hepatitis B
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublicationd7a9ea11-69fc-4122-a365-8fb2123512e6
relation.isAuthorOfPublication.latestForDiscoveryd7a9ea11-69fc-4122-a365-8fb2123512e6

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Gurel_vd_2007.pdf
Size:
66.75 KB
Format:
Adobe Portable Document Format
Download

Collections

Yeni Yayınlar